152 related articles for article (PubMed ID: 10404084)
1. Association between CYP17 gene polymorphism and risk of breast cancer in young women.
Bergman-Jungeström M; Gentile M; Lundin AC; Wingren S
Int J Cancer; 1999 Aug; 84(4):350-3. PubMed ID: 10404084
[TBL] [Abstract][Full Text] [Related]
2. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.
Haiman CA; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
Cancer Res; 1999 Mar; 59(5):1015-20. PubMed ID: 10070957
[TBL] [Abstract][Full Text] [Related]
3. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.
Chakraborty A; Murthy NS; Chintamani C; Bhatnagar D; Mohil RS; Sharma PC; Saxena S
J Hum Genet; 2007; 52(2):159-165. PubMed ID: 17235448
[TBL] [Abstract][Full Text] [Related]
4. CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
Verla-Tebit E; Wang-Gohrke S; Chang-Claude J
Breast Cancer Res; 2005; 7(4):R455-64. PubMed ID: 15987450
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of CYP17 and breast cancer risk in Korean women.
Shin MH; Lee KM; Yang JH; Nam SJ; Kim JW; Yoo KY; Park SK; Noh DY; Ahn SH; Kim B; Kang D
Exp Mol Med; 2005 Feb; 37(1):11-7. PubMed ID: 15761247
[TBL] [Abstract][Full Text] [Related]
6. The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.
Ye Z; Parry JM
Mutagenesis; 2002 Mar; 17(2):119-26. PubMed ID: 11880540
[TBL] [Abstract][Full Text] [Related]
7. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.
Spurdle AB; Hopper JL; Dite GS; Chen X; Cui J; McCredie MR; Giles GG; Southey MC; Venter DJ; Easton DF; Chenevix-Trench G
J Natl Cancer Inst; 2000 Oct; 92(20):1674-81. PubMed ID: 11036113
[TBL] [Abstract][Full Text] [Related]
8. A polymorphism in the CYP17 gene is associated with prostate cancer risk.
Gsur A; Bernhofer G; Hinteregger S; Haidinger G; Schatzl G; Madersbacher S; Marberger M; Vutuc C; Micksche M
Int J Cancer; 2000 Aug; 87(3):434-7. PubMed ID: 10897051
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T
Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764
[TBL] [Abstract][Full Text] [Related]
11. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
[TBL] [Abstract][Full Text] [Related]
12. CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors.
Ambrosone CB; Moysich KB; Furberg H; Freudenheim JL; Bowman ED; Ahmed S; Graham S; Vena JE; Shields PG
Breast Cancer Res; 2003; 5(2):R45-51. PubMed ID: 12631398
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism in CYP17 and breast cancer risk in Japanese women.
Miyoshi Y; Iwao K; Ikeda N; Egawa C; Noguchi S
Eur J Cancer; 2000 Dec; 36(18):2375-9. PubMed ID: 11094312
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17.
Carey AH; Waterworth D; Patel K; White D; Little J; Novelli P; Franks S; Williamson R
Hum Mol Genet; 1994 Oct; 3(10):1873-6. PubMed ID: 7849715
[TBL] [Abstract][Full Text] [Related]
16. CYP17, catechol-o-methyltransferase, and glutathione transferase M1 genetic polymorphisms, lifestyle factors, and breast cancer risk in women on Prince Edward Island.
Cribb AE; Joy Knight M; Guernsey J; Dryer D; Hender K; Shawwa A; Tesch M; Saleh TM
Breast J; 2011; 17(1):24-31. PubMed ID: 21129090
[TBL] [Abstract][Full Text] [Related]
17. CYP17 gene polymorphism in relation to breast cancer risk: a case-control study.
Einarsdóttir K; Rylander-Rudqvist T; Humphreys K; Ahlberg S; Jonasdottir G; Weiderpass E; Chia KS; Ingelman-Sundberg M; Persson I; Liu J; Hall P; Wedrén S
Breast Cancer Res; 2005; 7(6):R890-6. PubMed ID: 16280037
[TBL] [Abstract][Full Text] [Related]
18. HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore.
Wu AH; Seow A; Arakawa K; Van Den Berg D; Lee HP; Yu MC
Int J Cancer; 2003 Apr; 104(4):450-7. PubMed ID: 12584742
[TBL] [Abstract][Full Text] [Related]
19. CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women.
Henningson M; Johansson U; Borg A; Olsson H; Jernström H
Mol Hum Reprod; 2007 Apr; 13(4):231-6. PubMed ID: 17307805
[TBL] [Abstract][Full Text] [Related]
20. A polymorphism in the CYP17 gene increases the risk of breast cancer.
Feigelson HS; Coetzee GA; Kolonel LN; Ross RK; Henderson BE
Cancer Res; 1997 Mar; 57(6):1063-5. PubMed ID: 9067272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
